Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProcook Grp Regulatory News (PROC)

Share Price Information for Procook Grp (PROC)

Share Price is delayed by 15 minutes
Get Live Data
35.00    0.00 (0.00%)
Bid:
35.00
Ask:
37.00
Spread: 2.00 (5.714%)
Market Cap: £36.91m
PROC Live PriceLast checked at - London Stock Exchange

Intraday Procook Grp Share Chart

CEO Appointment

21 Aug 2023 07:00

RNS Number : 8464J
ProCook Group PLC
21 August 2023
 

21 August 2023

ProCook Group plc

Board Changes

CEO Appointment

 

Further to the announcement made on 7 July 2023, ProCook Group plc (the 'Company') confirms that, effective 18 September 2023:

(i) Lee Tappenden will join the Board as a Director and Chief Executive Officer of the Company. Lee brings extensive leadership, retail and consumer experience, having spent over 25 years with Walmart Stores and Asda, where he held a range of senior management roles. His tenure included roles in merchandising and operations, before becoming Chief Operations Officer, and then President and CEO of Walmart Canada.

(ii) Daniel O'Neill will remain in the role of CEO until Lee joins the Group, and will be available as required to support an orderly transition. Having founded ProCook over 27 years ago, the Group will continue to benefit from Daniel's deep knowledge of the business. He will remain on the Board, transitioning to a Non-Executive Director role, supporting the Group's continued development, with a particular focus on his passion for continually improving the product range.

This announcement is made pursuant to LR 9.6.12 of the Financial Conduct Authority's Listing Rules.

 

 

For further information please contact:

ProCook Group plc

Daniel O'Neill, Chief Executive Officer & Founder

Dan Walden, Chief Financial Officer

investor.relations@procook.co.uk

 

 

MHP Group (Financial PR Adviser)

Katie Hunt

Catherine Chapman

procook@mhpgroup.com

Tel: +44 (0)7711 191 518

 

 

 

Notes to editors:

ProCook is the UK's leading direct-to-consumer specialist kitchenware brand. ProCook offers a direct-to-consumer proposition, designing, developing, and retailing a high-quality range of cookware, kitchenware and tableware which provides customers with significant value for money.

The brand sells directly through its website, www.procook.co.uk, and through 58 own-brand retail stores, located across the UK.

Founded over 25 years ago as a family business, selling cookware sets by direct mail in the UK, ProCook has grown into a market leading, multi-channel specialist kitchenware company, employing over 600 colleagues, and operating from its HQ in Gloucester.

ProCook has been listed on the London Stock Exchange since November 2021 (PROC.L).

Further information about the ProCook Group can be found at www.procookgroup.co.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKKBPFBKDPFB
12
Date   Source Headline
14th Apr 20267:00 amRNSFourth quarter trading update
22nd Jan 202612:49 pmRNSPDMR Shareholding
14th Jan 20267:00 amRNSThird quarter trading update
10th Dec 20257:00 amRNSInterim Results
21st Nov 202511:00 amRNS-RInvestor Presentation via Investor Meet Company
15th Oct 20257:00 amRNSSecond quarter trading update
29th Sep 20258:01 amRNS-RProCook to open 5 stores before Christmas period
11th Sep 20259:24 amRNSResult of AGM
13th Aug 20257:00 amRNSNotice of AGM
3rd Jul 20253:18 pmRNSAnnual Report and Accounts
3rd Jul 20252:16 pmRNSGrant of Executive Share Awards
25th Jun 20257:00 amRNSAnnual Results
13th Jun 202510:00 amRNS-RInvestor Presentation via Investor Meet Company
13th Jun 20257:00 amRNSNotice of Full Year Results Date
22nd Apr 20255:30 pmRNSDirector/PDMR Shareholding
16th Apr 20257:00 amRNSFourth quarter trading update
5th Mar 20259:00 amRNSExercise of Options and PDMR Dealing
8th Jan 20257:00 amRNSThird quarter trading update
18th Dec 202412:02 pmRNSDirector Declaration
11th Dec 20247:00 amRNSInterim Results
5th Dec 20247:00 amRNS-RInvestor Presentation via Investor Meet Company
2nd Dec 20247:00 amRNSPublication of B Corp Impact Report 2024
16th Oct 20247:00 amRNSSecond quarter trading update
12th Sep 20247:00 amRNSResult of AGM
2nd Aug 202410:21 amRNSNotice of AGM
16th Jul 20242:13 pmRNSDirector/PDMR Shareholding
3rd Jul 202410:40 amRNSAnnual Report and Accounts
26th Jun 20247:00 amRNSAnnual Results
2nd May 20247:00 amRNSBoard Changes
9th Apr 20247:00 amRNSFourth quarter trading update
15th Mar 20241:15 pmRNSDirector/PDMR Dealing – Late Notification
6th Mar 202410:00 amRNSDirector Declaration
1st Feb 20244:12 pmRNSDirector/PDMR Shareholding
29th Jan 20244:58 pmRNSDirector/PDMR Shareholding
15th Jan 20243:29 pmRNSDirector/PDMR Shareholding
10th Jan 20247:00 amRNSThird quarter trading update
21st Dec 20234:45 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSInterim Results
1st Dec 20237:00 amRNSPublication of B Corp Impact Report 2023
20th Oct 20237:00 amRNSSecond quarter trading update
20th Sep 20237:00 amRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSResult of AGM
7th Sep 202311:26 amRNSDirector/PDMR Shareholding
21st Aug 20237:00 amRNSCEO Appointment
11th Aug 20231:37 pmRNSNotice of AGM
2nd Aug 20231:08 pmRNSAnnual Report and Accounts
7th Jul 20237:00 amRNSCEO Appointment
28th Jun 20237:06 amRNSPreliminary Results
7th Jun 202311:37 amRNSHolding(s) in Company
9th May 20231:59 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.